|Author(s)/Faculty: Patricia K. Coyle, MD, FAAN, FANA; Bruce A. Cohen, MD; Robert J. Fox, MD|
|Release Date: 7/11/2017||Expiration Date: 7/10/2018|
|Credit Type: CME / CNE||Number of Credits: 0.75|
|Content Type: Video||Provider: |
|Multiple sclerosis (MS) is a progressive, immune-mediated, neurodegenerative disease that is associated with irreversible physical disability and functional impairment. Due to its heterogeneity, treatment of patients with MS is highly individualized. This CME/CNE activity is designed to help clinicians integrate the latest clinical evidence on disease-modifying therapy with patient needs and preferences to develop effective, individualized treatment plans. Expert faculty will engage in a roundtable discussion about the benefits and risks of MS treatment options as well as ways to optimize patient management through shared decision making.